Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112840
Status:
COMPLETED
Last Update Posted:
2022-02-01
First Post:
2005-06-02
Brief Title:
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Renal Cell Cancer |
| Clear Cell Renal Cell Carcinoma |
| Recurrent Renal Cell Cancer |
Keywords: